Orion OYJ (ORINY) Stock Price, News & Analysis

Company Overview

Orion Oyj is a Finnish pharmaceutical company that develops, manufactures and markets medicines for human and veterinary use. Its portfolio includes prescription and over-the-counter medicines, as well as active pharmaceutical ingredients supplied to other pharmaceutical companies.

Founded in 1917 and headquartered in Espoo, Finland, Orion has a long history in the pharmaceutical industry. The company focuses on areas including oncology, neurology and respiratory diseases, and develops some products in collaboration with international pharmaceutical partners.

Orion serves customers in Finland and other European markets, while partnerships and product sales extend its reach to markets around the world. Its operations also include research and development, manufacturing and the commercialization of medicines.

Key Stats

• Today's Range: $57.89 to $57.89
• 50-Day Range: $45.77 to $58.15
• 52-Week Range: $33.63 to $58.15
• Volume: 1,033 shs
• Average Volume: 809 shs
• Market Capitalization: $16.34 billion
• P/E Ratio: 21.36
• Dividend Yield: 0.62%
• Price Target: N/A
• Consensus Rating: Buy

Orion OYJ Stock Analysis - MarketRank™

Orion OYJ scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Buy

Consensus Rating

Orion OYJ has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Orion OYJ has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Orion OYJ is 21.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.68.

Price to Earnings Ratio vs. Sector

The P/E ratio of Orion OYJ is 21.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.37.

Price to Book Value per Share Ratio

Orion OYJ has a P/B Ratio of 11.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Orion OYJ has been sold short.

Short Interest Ratio / Days to Cover

Orion OYJ has a short interest ratio ("days to cover") of 2.33, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Orion OYJ has recently increased by 5,345.28%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Orion OYJ has a dividend yield of 0.63%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Orion OYJ does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Orion OYJ is 13.28%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Sentiment

Orion OYJ has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Orion OYJ this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Orion OYJ insiders have not sold or bought any company stock.

Percentage Held by Institutions

Orion OYJ has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 10/28/2026
• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ORINY
• Previous Symbol: NASDAQ:ORINY
• CIK: N/A
• Web: www.orionpharma.com
• Phone: 358 10 4261
• Fax: N/A
• Employees: 4,029
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $2.71
• Trailing P/E Ratio: 21.36
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $566.04 million
• Net Margins: 30.25%
• Pretax Margin: 35.39%
• Return on Equity: 54.09%
• Return on Assets: 33.33%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 2.64
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $2.14 billion
• Price / Sales: 7.65
• Cash Flow: $2.26 per share
• Price / Cash Flow: 25.65
• Book Value: $5.15 per share
• Price / Book: 11.24

Miscellaneous

• Outstanding Shares: 282,270,000
• Free Float: N/A
• Market Cap: $16.34 billion
• Optionable: Not Optionable
• Beta: 0.05